martes, 5 de julio de 2016

New Drug Safety Podcasts- Drug Information Update

FDA logo, hand holding tablets, Division of Drug Information, Know the moment it happens
The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.

FDA's Division of Drug Information has posted new Drug Safety Podcasts for Healthcare Professionals. Click on the following links to read transcripts and listen to podcasts.
  • FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch.
    Listen icon
    Read Transcript Icon
  • FDA warns about serious bleeding risk with over-the-counter antacid products containing aspirin.
    Listen iconRead Transcript Icon
  • FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse. 
    Listen iconRead Transcript Icon
  • Update: FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch.
    Listen iconRead Transcript Icon
  • FDA strengthens kidney warnings for diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR).
    Listen iconRead Transcript Icon 

No hay comentarios:

Publicar un comentario